Natera

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Natera 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NTRA

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). 

CEO
Stephen Leonard Chapman
CEOStephen Leonard Chapman
Employees
4,434
Employees4,434
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
2003
Founded2003
Employees
4,434
Employees4,434

NTRA Key Statistics

Market cap
23.23B
Market cap23.23B
Price-Earnings ratio
-89.03
Price-Earnings ratio-89.03
Dividend yield
Dividend yield
Average volume
1.13M
Average volume1.13M
High today
$173.56
High today$173.56
Low today
$167.99
Low today$167.99
Open price
$173.21
Open price$173.21
Volume
946.04K
Volume946.04K
52 Week high
$183.00
52 Week high$183.00
52 Week low
$117.27
52 Week low$117.27

NTRA News

Simply Wall St 17h
Natera Valuation in Focus After New Clinical Advances in Cancer and Prenatal Testing

Natera (NTRA) has drawn renewed attention after announcing the successful enrollment of over 1,600 participants in its pivotal EXPAND trial for the Fetal Focus...

Natera Valuation in Focus After New Clinical Advances in Cancer and Prenatal Testing
Simply Wall St 6d
Natera's Enrollment Surge in EXPAND Trial Could Be a Game Changer for Natera

Natera recently announced a major milestone in its EXPAND clinical trial, surpassing 1,600 enrolled patients for the Fetal Focus single gene noninvasive prenata...

Natera's Enrollment Surge in EXPAND Trial Could Be a Game Changer for Natera

Analyst ratings

90%

of 21 ratings
Buy
90.5%
Hold
4.8%
Sell
4.8%

People also own

Based on the portfolios of people who own NTRA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.